Watermark
  Back to Search Results

BGB-3111-305

Completed

A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-3111-305

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT03734016

EudraCT or EUCT Number Info icon SVG graphic used for tooltips or additional information.

2018-001366-42

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20190098

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Plain Language Summary Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Plain Language Summary Study Protocol Statistical Analysis Plan